{
    "medicine_id": "162225427a28c701b0625253fbea94fd14de67ec",
    "platform_id": "DB00750",
    "metadata": {
        "name": "4 Citanest Forte Dental With Epinephrine 1 200 000 25 MG G Cream",
        "composition": "25 MG G Prilocaine",
        "clinical_particulars": {
            "therapeutic_indications": "Used as a local anaesthetic and is often used in dentistry",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Prilocaine binds to the intracellular surface of sodium channels which blocks the subsequent influx of sodium into the cell Action potential propagation and never function is therefore prevented This block is reversible and when the drug diffuses away from the cell sodium channel function is restored and nerve propagation returns",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of methemoglobinemia can be increased when Quinine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of methemoglobinemia can be increased when Celecoxib is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01086",
                        "description": "The risk or severity of methemoglobinemia can be increased when Benzocaine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of methemoglobinemia can be increased when Primaquine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of methemoglobinemia can be increased when Metoclopramide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of methemoglobinemia can be increased when Antipyrine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "The risk or severity of methemoglobinemia can be increased when Phenazopyridine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The risk or severity of methemoglobinemia can be increased when Amyl Nitrite is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of methemoglobinemia can be increased when Isometheptene is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB06795",
                        "description": "The risk or severity of methemoglobinemia can be increased when Mafenide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of methemoglobinemia can be increased when Nitrous oxide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00259",
                        "description": "The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00891",
                        "description": "The risk or severity of methemoglobinemia can be increased when Sulfapyridine is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB00070",
                        "description": "Hyaluronidase ovine can cause an increase in the absorption of Prilocaine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06205",
                        "description": "Hyaluronidase human recombinant can cause an increase in the absorption of Prilocaine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB14740",
                        "description": "Hyaluronidase can cause an increase in the absorption of Prilocaine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Prilocaine"
                    },
                    {
                        "drugbank-id": "DB09266",
                        "description": "Prilocaine may decrease effectiveness of Technetium Tc 99m tilmanocept as a diagnostic agent"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}